TEMPUS AI Share Price Today: Live Updates & Key Insights

TEMPUS AI share price today is $47.63, up -3.65%. The stock opened at $48.5 against the previous close of $48.74, with an intraday high of $49.315 and low of $46.14.

TEMPUS AI Share Price Chart

TEMPUS AI

us-stock
To Invest in {{usstockname}}
us-stock

TEMPUS AI Share Price Performance

$47.63 -0.0365(-3.65%) TEM at 23 Mar 2026 03:27 PM Health Information Services
Lowest Today 46.14
Highest Today 49.315
Today’s Open 48.5
Prev. Close 48.74
52 Week High 104.32
52 Week Low 36.22
Day’s Range: Low 46.14 High 49.315
52-Week Range: Low 36.22 High 104.32
1 day return -
1 Week return -7.62
1 month return -18.01
3 month return -28.73
6 month return -45.24
1 year return -20.4
3 year return -
5 year return -
10 year return -

TEMPUS AI Institutional Holdings

TEMPUS AI Market Status

Strong Buy: 4

Buy: 2

Hold: 6

Sell: 0

Strong Sell: 0

TEMPUS AI Fundamentals

Market Cap 8395.21 M

PB Ratio 17.7345

PE Ratio 0.0

Enterprise Value 9285.56 M

Total Assets 2274.84 M

Volume 4583157

TEMPUS AI Company Financials

Annual Revenue FY25:1271789000 1271.8M, FY24:693398000 693.4M, FY23:531822000 531.8M

Annual Profit FY25:885687000 885.7M, FY24:381113000 381.1M, FY23:286175000 286.2M

Annual Net worth FY25:-245028000 -245.0M, FY24:-705809000 -705.8M, FY23:-214118000 -214.1M

Quarterly Revenue Q4/2025:367211000 367.2M, Q3/2025:334206000 334.2M, Q2/2025:314635000 314.6M, Q1/2025:255737000 255.7M, Q4/2024:200680000 200.7M

Quarterly Profit Q4/2025:329539000 329.5M, Q3/2025:205906000 205.9M, Q2/2025:195039000 195.0M, Q1/2025:155203000 155.2M, Q4/2024:122064000 122.1M

Quarterly Net worth Q4/2025:-54166000 -54.2M, Q3/2025:-79982000 -80.0M, Q2/2025:-42843000 -42.8M, Q1/2025:-68037000 -68.0M, Q4/2024:-13014000 -13.0M

About TEMPUS AI & investment objective

Company Information Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests. The company also provides Lens, a software application for life sciences and advanced precision research; diagnostics services, such as NGS diagnostics, PCR profiling, and other anatomic and molecular pathology tests; and large-panel solid tumor and hematologic testing through multiple assays, with its core clinical assay (xT and xR) offering large panel DNA, RNA full transcriptome, and incidental germline findings through normal blood or saliva analyses. In addition, it provides genetic tests focused on inherited conditions; an nP assay for pharmacogenomic testing for patients with psychiatric conditions, including depression, general anxiety disorder, bipolar disorder, and other relevant diagnoses; Insights, which licenses libraries of linked, de-identified clinical, molecular, and imaging data; Organoids, a tumor derived biological modeling. Further, the company offers Trials for clinical trial matching services; Next, an AI platform; Algos, an algorithm-based diagnostics application. It has Strategic Collaborations with AstraZeneca AB, Pathos AI, Inc., GlaxoSmithKline, Merck, and Recursion Pharmaceuticals, Inc. Additionally, it also has a strategic collaboration with Blood Cancer United to develop registry for pediatric acute myeloid leukemia. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.

Organisation Health Information Services

Employees 3800

Industry Health Information Services

CEO Mr. Eric P. Lefkofsky J.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

TEMPUS AI FAQs

What is the share price of TEMPUS AI today?

The current share price of TEMPUS AI is $47.63.

Can I buy TEMPUS AI shares in India?

Yes, Indian investors can buy TEMPUS AI shares by opening an international trading and demat account with Motilal Oswal.

How to buy TEMPUS AI shares in India?

You can easily invest in TEMPUS AI shares from India by:

Can I buy fractional shares of TEMPUS AI?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of TEMPUS AI?

TEMPUS AI has a market cap of $8395.21 M.

In which sector does TEMPUS AI belong?

TEMPUS AI operates in the Health Information Services sector.

What documents are required to invest in TEMPUS AI stocks?

To invest, you typically need:

What is the PE and PB ratio of TEMPUS AI?

The PE ratio of TEMPUS AI is N/A and the PB ratio is 17.73.